Follistim Aq Cartridge Generic Name & Formulations
Legal Class
General Description
How Supplied
Manufacturer
Generic Availability
Mechanism of Action
Follistim Aq Cartridge Indications
Indications
Follistim Aq Cartridge Dosage and Administration
Adult
Children
Follistim Aq Cartridge Contraindications
Contraindications
Primary gonadal failure. Uncontrolled thyroid, adrenal, or pituitary disorders. Tumors of the ovary, breast, uterus, testis, hypothalamus or pituitary gland. Streptomycin or neomycin allergy. Pregnancy. Undiagnosed abnormal vaginal bleeding. Ovarian cysts or enlargement.
Follistim Aq Cartridge Boxed Warnings
Not Applicable
Follistim Aq Cartridge Warnings/Precautions
Warnings/Precautions
Follistim Aq Cartridge Pharmacokinetics
Absorption
Cmax in healthy, pituitary-suppressed, women: 5.41 ± 0.72 international units/L (for SC administration); 6.86 ± 2.90 international units/L (for IM administration).
Apparent dose absorbed: 77.8% (for SC administration); 76.4% (for IM administration).
Distribution
Volume of distribution in healthy, pituitary-suppressed, women following IV administration of a 300 international units dose: ~8 L.
Elimination
Renal.
Half-life: 33.4 hours.
Clearance: 0.01 L/h/kg.
Follistim Aq Cartridge Interactions
Not Applicable
Follistim Aq Cartridge Adverse Reactions
Adverse Reactions
Follistim Aq Cartridge Clinical Trials
See Literature
Follistim Aq Cartridge Note
Not Applicable
Follistim Aq Cartridge Patient Counseling
See Literature